Major histocompatibility complex class II-transfected tumor cells present endogenous antigen and are potent inducers of tumor-specific immunity

We have developed an immunotherapy in which tumor cells transfected with syngeneic major histocompatibility complex (MHC) class II genes are cell-based vaccines for the treatment of established tumor and metastatic disease. If this strategy is to be used clinically, convenient methods for generating...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Proc Natl Acad Sci U S A
Principais autores:	Armstrong, Todd D., Clements, Virginia K., Martin, Brian K., Ting, Jenny P.-Y., Ostrand-Rosenberg, Suzanne
Formato:	Artigo
Idioma:	Inglês
Publicado em:	National Academy of Sciences 1997
Assuntos:	Biological Sciences
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC21254/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9192661/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.94.13.6886
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!